Glutathione‐Depleted Photodynamic Nanoadjuvant for Triggering Nonferrous Ferroptosis to Amplify Radiotherapy of Breast Cancer
Source abstract
Abstract
Abstract Radiotherapy plays a crucial role in the treatment of advanced breast cancer, but the increased antioxidant system, especially the rise in glutathione (GSH), presents a significant obstacle to its effectiveness. To address this challenge, a versatile GSH‐depleted photodynamic nanoadjuvant is developed to augment the efficacy of radiotherapy for breast cancer treatment. This nanoadjuvant operates within the tumor microenvironment to effectively deplete intracellular GSH through a sequence of cascaded processes, including GSH exhaustion, biosynthetic inhibition, and photodynamic oxidation. This leads to a notable accumulation of lipid peroxides (LPO) and subsequent suppression of glutathione peroxidase 4 (GPX4) activity. Consequently, the combined GSH depletion induced by the nanoadjuvant markedly promotes nonferrous ferroptosis, thereby contributing to the augmentation of antitumor efficiency during radiotherapy in breast cancer. This work presents an innovative approach to designing and synthesizing biocompatible nanoadjuvants with the goal of improving the efficacy of radiotherapy for breast cancer in prospective clinical scenarios.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Sulfur Compounds in Biology · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Radiation Medicine and Protection Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School of Radiation Medicine and Protection Soochow University Suzhou 215123 China
Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences Soochow University Suzhou 215123 China
School of Chemistry and Life Sciences Suzhou University of Science and Technology Suzhou 215000 China
Funding
National Natural Science Foundation of China
References (53)
Show source-provided references
1. 10.1056/NEJMoa220758610.1056/NEJMoa2207586 ↗
2. 10.1038/s41572-019-0111-210.1038/s41572-019-0111-2 ↗
3. 10.1016/S0140-6736(21)00233-610.1016/S0140-6736(21)00233-6 ↗
4. 10.1089/ars.2013.548910.1089/ars.2013.5489 ↗
5. 10.1002/adma.20210055610.1002/adma.202100556 ↗
6. 10.1021/acsnano.2c0231410.1021/acsnano.2c02314 ↗
7. 10.1080/1040836050052387810.1080/10408360500523878 ↗
8. 10.1002/anie.20171202710.1002/anie.201712027 ↗
9. 10.1016/j.biomaterials.2021.12111010.1016/j.biomaterials.2021.121110 ↗
10. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
11. 10.1016/S0009-2797(97)00164-610.1016/S0009-2797(97)00164-6 ↗
12. 10.1002/anie.20220284310.1002/anie.202202843 ↗
13. 10.1111/cpr.1315810.1111/cpr.13158 ↗
14. 10.1007/s10238-022-00972-410.1007/s10238-022-00972-4 ↗
15. 10.3892/or.2013.222810.3892/or.2013.2228 ↗
16. 10.1038/s41416-022-01965-610.1038/s41416-022-01965-6 ↗
17. 10.1039/D0CS00718H10.1039/D0CS00718H ↗
18. 10.1021/acsnano.1c0049810.1021/acsnano.1c00498 ↗
19. 10.1002/adhm.20230341210.1002/adhm.202303412 ↗
20. 10.1002/adma.20170099610.1002/adma.201700996 ↗
21. 10.1002/adma.20180224410.1002/adma.201802244 ↗
22. 10.1002/adma.20220628610.1002/adma.202206286 ↗
23. 10.1021/acs.nanolett.8b0390510.1021/acs.nanolett.8b03905 ↗
24. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
25. 10.1021/acs.chemrev.1c0038110.1021/acs.chemrev.1c00381 ↗
26. 10.1021/acsnano.3c0089110.1021/acsnano.3c00891 ↗
27. 10.1002/anie.20231648710.1002/anie.202316487 ↗
28. 10.1021/acsami.2c2209510.1021/acsami.2c22095 ↗
29. 10.1002/adma.20210679710.1002/adma.202106797 ↗
30. 10.1002/adma.20200422510.1002/adma.202004225 ↗
31. 10.1021/jacs.3c1241610.1021/jacs.3c12416 ↗
32. 10.3390/cancers1520504310.3390/cancers15205043 ↗
33. 10.1002/adfm.20230952410.1002/adfm.202309524 ↗
34. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
35. 10.1021/acsami.1c2186010.1021/acsami.1c21860 ↗
36. 10.1021/cr300358b10.1021/cr300358b ↗
37. 10.1038/s41467-023-37872-410.1038/s41467-023-37872-4 ↗
38. 10.1016/j.ccr.2017.09.02910.1016/j.ccr.2017.09.029 ↗
39. 10.1016/j.addr.2018.07.00710.1016/j.addr.2018.07.007 ↗
40. 10.1039/D0TB00609B10.1039/D0TB00609B ↗
41. 10.1021/jp051163i10.1021/jp051163i ↗
42. 10.1172/JCI12990310.1172/JCI129903 ↗
43. 10.3390/biom1010142910.3390/biom10101429 ↗
44. 10.1038/cdd.2015.15810.1038/cdd.2015.158 ↗
45. 10.1016/j.jconrel.2023.03.03010.1016/j.jconrel.2023.03.030 ↗
46. 10.1038/s41467-023-39401-910.1038/s41467-023-39401-9 ↗
47. 10.1021/acsami.9b1095410.1021/acsami.9b10954 ↗
48. 10.1038/s41418-019-0393-710.1038/s41418-019-0393-7 ↗
49. 10.1016/j.lfs.2006.04.02410.1016/j.lfs.2006.04.024 ↗
50. 10.1002/cac2.1225010.1002/cac2.12250 ↗
51. 10.1038/s41419-022-05384-610.1038/s41419-022-05384-6 ↗
52. 10.1002/smll.20210765610.1002/smll.202107656 ↗
53. 10.1038/s41551-018-0234-x10.1038/s41551-018-0234-x ↗